AR227731A1 - Procedimiento para obtener nuevos derivados de((piperidil-2)-2-etil)-4-quinoleina y sus sales - Google Patents

Procedimiento para obtener nuevos derivados de((piperidil-2)-2-etil)-4-quinoleina y sus sales

Info

Publication number
AR227731A1
AR227731A1 AR22773182D AR22773182D AR227731A1 AR 227731 A1 AR227731 A1 AR 227731A1 AR 22773182 D AR22773182 D AR 22773182D AR 22773182 D AR22773182 D AR 22773182D AR 227731 A1 AR227731 A1 AR 227731A1
Authority
AR
Argentina
Prior art keywords
piperidil
quinolein
etil
salts
procedure
Prior art date
Application number
AR22773182D
Other languages
English (en)
Original Assignee
Pharmindustrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmindustrie filed Critical Pharmindustrie
Application granted granted Critical
Publication of AR227731A1 publication Critical patent/AR227731A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
AR22773182D 1980-06-20 1982-01-01 Procedimiento para obtener nuevos derivados de((piperidil-2)-2-etil)-4-quinoleina y sus sales AR227731A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8013698A FR2485014A1 (fr) 1980-06-20 1980-06-20 Nouveaux derives de (quinolyl-2, -3 ou -4)-1 (piperidyl ou pyrrolidinyl-2 ou -3)-2 ou -3 ethanone ou propanone, procedes pour leur preparation, et leur utilisation comme medicaments

Publications (1)

Publication Number Publication Date
AR227731A1 true AR227731A1 (es) 1982-11-30

Family

ID=9243305

Family Applications (1)

Application Number Title Priority Date Filing Date
AR22773182D AR227731A1 (es) 1980-06-20 1982-01-01 Procedimiento para obtener nuevos derivados de((piperidil-2)-2-etil)-4-quinoleina y sus sales

Country Status (16)

Country Link
US (1) US4402961A (es)
EP (1) EP0042781B1 (es)
JP (1) JPS57102885A (es)
AR (1) AR227731A1 (es)
AU (1) AU537379B2 (es)
CA (1) CA1184180A (es)
DE (1) DE3169169D1 (es)
DK (1) DK271981A (es)
ES (3) ES503166A0 (es)
FR (1) FR2485014A1 (es)
GR (1) GR75685B (es)
IL (1) IL63125A0 (es)
MA (1) MA19184A1 (es)
NO (1) NO812105L (es)
PT (1) PT73232B (es)
ZA (1) ZA814126B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2471981A1 (fr) * 1979-12-21 1981-06-26 Pharmindustrie Nouveaux derives de la (piperidyl-4)-2 (quinolyl-4)-1 ethanone, produits intermediaires et procedes pour leur preparation, et leur utilisation comme medicaments
IL62240A0 (en) * 1980-03-06 1981-05-20 Acf Chemiefarma Nv Novel quinoline derivatives,pharmaceutical compositions containing such compounds,and methods for the preparation of these compounds
GR74482B (es) * 1980-03-06 1984-06-28 Acf Chemiefarma Nv
FR2495470A1 (fr) * 1980-12-05 1982-06-11 Pharmindustrie Nouveaux medicaments a base de derives de (quinolyl-4)-1 (piperidyl-4)-2 ethanol ou (quinolyl-4)-1 (piperidyl-4)-3 propanol
FR2525595A1 (fr) * 1982-04-27 1983-10-28 Pharmuka Lab Nouveaux derives d'arene et d'heteroarenecarboxamides et leur utilisation comme medicaments
US4560692A (en) * 1984-07-18 1985-12-24 Hoffmann-La Roche Inc. 4-Piperidino-2-phenylquinolines
FR2582514B1 (fr) * 1985-05-30 1988-02-19 Rhone Poulenc Sante Medicaments a base d'amides, nouveaux amides et leur preparation
FR2664592B1 (fr) * 1990-07-10 1994-09-02 Adir Nouveaux derives de la piperidine, de la tetrahydropyridine et de la pyrrolidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5240942A (en) * 1990-07-10 1993-08-31 Adir Et Compagnie Piperidine, tetrahydropyridine and pyrrolidine compounds
US5493024A (en) * 1991-04-11 1996-02-20 Dowelanco 3,4,N-trisubstituted-4,5-dihydro-1H-pyrazole-1-carboxamides and their use as insectioides
US6664271B1 (en) 1999-05-21 2003-12-16 Eli Lilly And Company Immunopotentiator agents
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
AU2001276556A1 (en) * 2000-08-11 2002-02-25 Smithkline Beecham P.L.C. Novel pharmaceutical use of quinnoline derivatives
US6376514B1 (en) * 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US6693099B2 (en) * 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US20040039206A1 (en) * 2001-11-13 2004-02-26 Moher Eric David Process for resolving racemic mixtures of piperidine derivatives
DE10256405A1 (de) * 2002-12-02 2004-06-17 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
US7348434B2 (en) 2003-08-08 2008-03-25 Antony Bigot 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them
FR2858619B1 (fr) * 2003-08-08 2006-12-22 Aventis Pharma Sa Derives de quinoleines-4-substituees, leurs procede et intermediaires de preparation et les compositions pharmaceutiques qui les contiennent
CA2780111A1 (en) * 2009-11-07 2011-05-12 Merck Patent Gmbh Heteroarylaminoquinolines as tgf-beta receptor kinase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR959917A (es) * 1946-06-25 1950-04-07
US3857837A (en) * 1968-07-02 1974-12-31 Hoffmann La Roche Processes and intermediated for quinine, quinidine, isomers and derivatives thereof
GB1441244A (en) * 1972-11-17 1976-06-30 Rech Et Dapplications Scient S Derivatives of quinoline and method of preparing the same
US3953453A (en) * 1973-12-07 1976-04-27 Hoffmann-La Roche Inc. Trifluoromethyl substituted analogs of quinine and quinidine
PT66682B (pt) * 1976-06-18 1978-11-15 Ind Biolog Francaise /(quinolyl-4)-propyl-1/-4 piperidines leur preparation et leur utilisation comme medicaments /(quinolyl-4)-propyl/-4 piperidines leur preparation et leur utilisation comme medicaments
FR2354771A1 (fr) * 1976-06-18 1978-01-13 Mar Pha Etu Expl Marques ((quinolyl-4)-3 propyl-1) -4 piperidines, leur preparation et leur utilisation comme medicaments
FR2381044A1 (fr) * 1977-02-17 1978-09-15 Hoffmann La Roche Procede pour la preparation de mefloquine
GR69926B (es) * 1978-03-23 1982-07-21 Pharmindustrie

Also Published As

Publication number Publication date
GR75685B (es) 1984-08-02
MA19184A1 (fr) 1981-12-31
FR2485014A1 (fr) 1981-12-24
ES8300748A1 (es) 1982-11-01
ZA814126B (en) 1982-06-30
AU7198381A (en) 1981-12-24
CA1184180A (fr) 1985-03-19
PT73232B (fr) 1982-07-30
US4402961A (en) 1983-09-06
AU537379B2 (en) 1984-06-21
EP0042781A1 (fr) 1981-12-30
EP0042781B1 (fr) 1985-03-06
IL63125A0 (en) 1981-09-13
ES8305354A1 (es) 1983-04-01
ES8305353A1 (es) 1983-04-01
ES513448A0 (es) 1983-04-01
FR2485014B1 (es) 1984-05-04
NO812105L (no) 1981-12-21
DK271981A (da) 1981-12-21
JPS57102885A (en) 1982-06-26
ES503166A0 (es) 1982-11-01
PT73232A (fr) 1981-07-01
DE3169169D1 (en) 1985-04-11
ES513449A0 (es) 1983-04-01

Similar Documents

Publication Publication Date Title
AR240807A1 (es) Procedimiento para obtener derivados de benzazepin-2-ona y sus sales
AR227731A1 (es) Procedimiento para obtener nuevos derivados de((piperidil-2)-2-etil)-4-quinoleina y sus sales
AR228444A1 (es) Procedimiento para preparar derivados de 5-bencil-tiazolidin-2,4-diona y sus sales
AR228575A1 (es) Procedimiento para obtener derivados de 7-hidroximetil o 7-carboxicamptotecina y sus sales
AR229103A1 (es) Procedimiento para la preparacion de derivados de 3-aril-5-isotiazol y sus sales
ES487464A0 (es) Procedimiento de preparacion de nuevos derivados aldehidos peptidil-argininos y de sus sales
AR225922A1 (es) Procedimiento para preparar nuevos derivados de 3-carbamoil-sulfonamido-4-amino-piridina y sus sales
AR230269A1 (es) Procedimiento para elaborar nuevos derivados de imidazol trisustituidos y sus sales
AR220539A1 (es) Procedimiento para obtener 7 beta-aril-malonamido-7 alpha-metoxi-3-(tiadiazoliltio)1-oxadetiacefalosporinas y sus sales
AR220686A1 (es) Procedimiento para obtener derivados de 2 amino-2-desoxi-3-o-(propilcarbamoilmetil)-carbamoilmetil-glucopiranosa y sus sales
ES506222A0 (es) Procedimiento de preparacion de acidos azabiciclohexano car-boxilicos y de sus sales
AR221080A1 (es) Procedimiento para obtener nuevos derivados de propanona y sus sales
AR227450A1 (es) Procedimiento para producir nuevos 8-arilalquil-3-fenil-3-nortropanoles y sus sales de adicion de acidos
AR230280A1 (es) Procedimiento para obtener derivados de carboestirilo y sus sales
ES502643A0 (es) Procedimiento para la preparacion de compuestos de aril-fe- nil-acetileno y sus sales amonicas
AR240044A1 (es) Procedimiento para elaborar nuevos derivados de la quinolinona y sus sales.
AR228144A1 (es) Procedimiento para obtener derivados de 5-fenil-triazolidina-2,4-diona y sus sales
AR212468A1 (es) Procedimiento para la preparacion de nuevos derivados de w-alquilamidas de acidos w amino-carboxilicos y sus sales
AR227272A1 (es) Procedimiento para la obtencion de compuestos de n-oxaciclil-alquil-piperidil-diaza y sus sales
ES530269A0 (es) Derivados de indano y sus sales
AR240828A1 (es) Procedimiento para obtener nuevos derivados de 1h,3h-pirrolo|1,2-c¨tiazol y sus sales
MX7130E (es) Procedimiento para preparar tetrahidrocorinanteina y sus sales de adicion de acido
AR228036A1 (es) Procedimiento para obtener derivados de 1-tio-alcanoilprolina y sus sales
AR223160A1 (es) Procedimiento para preparar derivados de 3-aminoalquiltiazolidindiona(2,4)y sus sales
AR226288A1 (es) Procedimiento para la produccion de nuevas 4-alquiltiofenoxi alquilaminas y sus sales